Credit Suisse analyst Nik Cremo maintains Verra Mobility (NASDAQ:VRRM) with a Outperform and lowers the price target from $19 to $18.
UroGen Pharma Sponsored Study Titled ‘Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle-Invasive Bladder Cancer (NMIBC)’ Posted To ClinicalTrials.gov; Study Is Recruiting
November 30, 11:43 AM
Bunny Tokens Leap Ahead Of Bitcoin, Ethereum And Dogecoin As Chinese New Year Brings Windfall For Crypto Investors
January 23, 7:04 AM
Bunny tokens are soaring in the wake of the Chinese New Year. 2023 in the Gregorian calendar is designated as the Year of the Rabbit.